| 24633336 | P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma. | Cancer Immunol Immunother | 2014 May | Terashima T | doi: 10.1007/s00262-014-1529-8 |
| 27062662 | Wilms' tumor 1 protein expression in endometrial adenocarcinoma and endometrial intra-epithelial neoplasia. | J Obstet Gynaecol Res | 2016 Jul | Atik Y | doi: 10.1111/jog.12981 |
| 25932444 | Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm. | Ann Lab Med | 2015 May | Kim N | doi: 10.3343/alm.2015.35.3.348 |
| 25932436 | Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population. | Ann Lab Med | 2015 May | Park SH | doi: 10.3343/alm.2015.35.3.288 |
| 26320177 | WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene. | Oncotarget | 2015 Sep 29 | Montano G | doi: 10.18632/oncotarget.4950. |
| 23874238 | Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus. | PLoS Genet | 2013 | Miller CL | doi: 10.1371/journal.pgen.1003652 |
| 19250757 | Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis. | Pathol Res Pract | 2009 | Al-Salam S | doi: 10.1016/j.prp.2009.01.012 |
| 20435628 | Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. | Haematologica | 2010 Jun | Heesch S | doi: 10.3324/haematol.2009.016386 |
| 21760594 | Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia. | Leukemia | 2011 Dec | Renneville A | doi: 10.1038/leu.2011.173 |
| 19847202 | Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies. | Leukemia | 2010 Feb | Renneville A | doi: 10.1038/leu.2009.221 |
| 26597595 | A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia. | Br J Haematol | 2016 Feb | Niavarani A | doi: 10.1111/bjh.13836 |
| 23706170 | Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomas. | Ann Diagn Pathol | 2013 Oct | Fadare O | doi: 10.1016/j.anndiagpath.2013.04.011 |
| 20016532 | Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD). | Leukemia | 2010 Mar | Abbas S | doi: 10.1038/leu.2009.265 |
| 18516627 | A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema. | Pediatr Nephrol | 2008 Sep | Wagner N | doi: 10.1007/s00467-008-0845-7 |
| 22242671 | Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma. | J Neurosurg | 2012 Apr | Chiba Y | doi: 10.3171/2011.12.JNS111255 |
| 24257751 | Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics. | J Biol Chem | 2014 Jan 10 | Rather MI | doi: 10.1074/jbc.M113.483255 |
| 21909685 | Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma. | Pathol Oncol Res | 2012 Apr | Singh A | doi: 10.1007/s12253-011-9456-x |
| 25447528 | Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC. | FEBS Lett | 2014 Dec 20 | Wu C | doi: 10.1016/j.febslet.2014.10.026 |
| 18260155 | Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. | Cancer | 2008 Apr 1 | Barbolina MV | doi: 10.1002/cncr.23341. |
| 27354645 | Immunohistochemical Analysis of WT1 Antigen Expression in Various Solid Cancer Cells. | Anticancer Res | 2016 Jul | Naitoh K | - |
| 22434317 | Desmoplastic small round cell tumor-clinicopathological spectrum, including unusual features and immunohistochemical analysis of 45 tumors diagnosed at a tertiary cancer referral centre, with molecular results t(11; 22) (p13; q12) (EWS-WT1) in select cases. | Pathol Oncol Res | 2012 Oct | Rekhi B | - |
| 24503796 | Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer. | Tumori | 2013 Nov-Dec | Tuna M | doi: 10.1700/1390.15461. |
| 18181329 | Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene. | J Med Assoc Thai | 2007 Nov | Navakanit R | - |
| 20871039 | WT1 expression correlates with angiogenesis in endometrial cancer tissue. | Anticancer Res | 2010 Aug | Dohi S | - |
| 28677722 | Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells. | Int J Mol Med | 2017 Sep | Li Y | doi: 10.3892/ijmm.2017.3051 |
| 18273617 | Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation. | Cancer Chemother Pharmacol | 2008 Nov | Lugtenberg RT | doi: 10.1007/s00280-008-0694-x |
| 19749460 | High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor. | Indian J Cancer | 2009 Oct-Dec | Gupta S | doi: 10.4103/0019-509X.55550. |
| 18703217 | A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity. | Hum Pathol | 2008 Dec | Murphy AJ | doi: 10.1016/j.humpath.2008.04.019 |
| 12914969 | Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. | Brain Res | 2003 Sep 5 | Lovell MA | - |
| 12200377 | CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. | Blood | 2002 Sep 15 | Scheibenbogen C | - |
| 14988155 | Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen. | Blood | 2004 Jun 15 | Savage P | - |
| 12239212 | Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor. | J Biol Chem | 2002 Nov 22 | Lee TH | - |
| 17721194 | Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. | Am J Surg Pathol | 2007 Sep | Zhao C | - |
| 25510679 | The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression. | Nat Commun | 2014 Dec 16 | Wagner KD | doi: 10.1038/ncomms6852. |
| 17487399 | VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells. | Oncol Rep | 2007 Jun | Cash J | - |
| 15957141 | Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy. | Am J Kidney Dis | 2005 Jun | Zirn B | - |
| 17540436 | Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish MALOVA ovarian cancer study. | Gynecol Oncol | 2007 Aug | Hogdall EV | - |
| 19549856 | An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. | Proc Natl Acad Sci U S A | 2009 Jul 7 | Kim MK | doi: 10.1073/pnas.0901591106 |
| 22510877 | Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1. | Blood | 2012 May 31 | Romano E | doi: 10.1182/blood-2011-09-382200 |
| 18722603 | Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study. | Fertil Steril | 2009 Apr | Coosemans A | doi: 10.1016/j.fertnstert.2008.06.042 |
| 16927106 | WT1 and glomerular diseases. | Pediatr Nephrol | 2006 Nov | Niaudet P | - |
| 25454478 | Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical course. | Hum Pathol | 2015 Jan | Ud Din N | doi: 10.1016/j.humpath.2014.09.015 |
| 21734473 | Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma. | Int J Gynecol Cancer | 2011 Feb | Coosemans A | doi: 10.1097/IGC.0b013e318207cab5. |
| 25748047 | Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis. | Sci Rep | 2015 Mar 9 | Qi XW | doi: 10.1038/srep08924. |
| 26224397 | Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia. | J Cancer Res Clin Oncol | 2015 Dec | Junghanns AS | doi: 10.1007/s00432-015-2018-y |
| 23142971 | Wilms' tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma. | J Gastroenterol | 2013 Sep | Uesugi K | doi: 10.1007/s00535-012-0708-7 |
| 22030397 | WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. | J Biol Chem | 2011 Dec 23 | McCarty G | doi: 10.1074/jbc.M111.310128 |
| 14767530 | Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene. | Int J Oncol | 2004 Mar | Fraizer G | - |
| 17205055 | Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. | Leukemia | 2007 Mar | Summers K | - |
| 23554000 | A novel WT1 mutation in familial wilms tumor. | Pediatr Blood Cancer | 2013 Aug | Melchionda F | doi: 10.1002/pbc.24539 |
| 22313360 | Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness. | J Neurosurg | 2012 Apr | Chidambaram A | doi: 10.3171/2011.11.JNS111455 |
| 12411326 | Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL. | Blood | 2002 Nov 15 | Bellantuono I | - |
| 26200099 | Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations. | Am J Surg Pathol | 2015 Oct | Irving JA | doi: 10.1097/PAS.0000000000000482. |
| 24619359 | Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation. | Hum Mol Genet | 2014 Aug 1 | Busch M | doi: 10.1093/hmg/ddu111 |
| 22673530 | Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. | Acta Histochem | 2013 Jan | Parenti R | doi: 10.1016/j.acthis.2012.04.006 |
| 19097357 | Examination of expression of WT1 gene product and CD44 adhesive molecule in nephroblastoma histologic types. | Pol J Pathol | 2008 | Taran K | - |
| 20736771 | WT1 immunoprofiling and comparison of malignant Mullerian mixed tumors of the female genital tract. | Int J Gynecol Pathol | 2010 Sep | Franko A | doi: 10.1097/PGP.0b013e3181d55597. |
| 17972942 | The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. | Leukemia | 2008 May | Tschan MP | - |
| 23480492 | Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma. | Leuk Lymphoma | 2013 Nov | Israyelyan A | doi: 10.3109/10428194.2013.783910 |
| 15253707 | Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. | Kidney Int | 2004 Aug | Ruf RG | - |
| 20595692 | Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. | Clin J Am Soc Nephrol | 2010 Sep | Chernin G | doi: 10.2215/CJN.09351209 |
| 19190340 | Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. | Cancer Res | 2009 Feb 15 | Perugorria MJ | doi: 10.1158/0008-5472.CAN-08-2545 |
| 12824878 | Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma. | Cancer Sci | 2003 Jun | Oji Y | - |
| 18528287 | Cytoplasmic overexpression of WT-1 in gastrointestinal stromal tumor and other soft tissue tumors. | Appl Immunohistochem Mol Morphol | 2008 Jul | Bing Z | doi: 10.1097/PAI.0b013e31815c2e02. |
| 19137020 | Canonical WNT signalling determines lineage specificity in Wilms tumour. | Oncogene | 2009 Feb 26 | Fukuzawa R | doi: 10.1038/onc.2008.455 |
| 24927120 | Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1). | Biochem J | 2014 Jul 1 | Toska E | doi: 10.1042/BJ20131587. |
| 28400619 | Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. | Leukemia | 2017 Dec | Lyu Y | doi: 10.1038/leu.2017.116 |
| 27417955 | WT1 Mutation in Childhood Cancer. | Methods Mol Biol | 2016 | Charlton J | doi: 10.1007/978-1-4939-4023-3_1. |
| 28498419 | miR-590 regulates WT1 during proliferation of G401 cells. | Mol Med Rep | 2017 Jul | Hong L | doi: 10.3892/mmr.2017.6561 |
| 22672247 | Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma. | J Oral Pathol Med | 2013 Feb | Mikami T | doi: 10.1111/j.1600-0714.2012.01182.x |
| 12127961 | Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. | Biochem Biophys Res Commun | 2002 Jul 26 | Zapata-Benavides P | - |
| 29040381 | The CUG-translated WT1, not AUG-WT1, is an oncogene. | Carcinogenesis | 2017 Dec 7 | Lee KY | doi: 10.1093/carcin/bgx108. |
| 23298185 | The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. | Mol Cancer | 2013 Jan 8 | Brett A | doi: 10.1186/1476-4598-12-3. |
| 18292948 | Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. | Int J Oncol | 2008 Mar | Tatsumi N | - |
| 23945386 | WT1 promotes invasion of NSCLC via suppression of CDH1. | J Thorac Oncol | 2013 Sep | Wu C | doi: 10.1097/JTO.0b013e31829f6a5f. |
| 22797561 | High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer. | Oncol Rep | 2012 Oct | Qi XW | doi: 10.3892/or.2012.1906 |
| 15365188 | Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. | Proc Natl Acad Sci U S A | 2004 Sep 21 | Oka Y | - |
| 18708366 | Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells. | Mol Cancer Res | 2008 Aug | Han Y | doi: 10.1158/1541-7786.MCR-07-2179. |
| 17599043 | Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. | Oncogene | 2008 Jan 3 | Caldon CE | - |
| 12841869 | Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer. | Cancer Sci | 2003 Jul | Oji Y | - |
| 12960088 | The WT1 Wilms' tumor suppressor gene: a novel target for insulin-like growth factor-I action. | Endocrinology | 2003 Oct | Bentov I | - |
| 25929687 | Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck. | BMC Cancer | 2015 May 1 | Li X | doi: 10.1186/s12885-015-1356-0. |
| 21867623 | [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2011 Aug | Zhang R | - |
| 17940140 | Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. | RNA | 2007 Dec | Dallosso AR | - |
| 17706117 | [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model]. | Zhonghua Bing Li Xue Za Zhi | 2007 Apr | Yang JL | - |
| 26573232 | A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. | Oncotarget | 2016 Jan 26 | Wu L | doi: 10.18632/oncotarget.5837. |
| 19443388 | Immunohistochemical detection of WT1 protein in endometrial cancer. | Anticancer Res | 2009 May | Ohno S | - |
| 14666652 | Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. | Anticancer Res | 2003 Sep-Oct | Zhang TF | - |
| 23888944 | Transcription factor WT1 and promoter CpG hypomethylation coactivate HOXA10 expression in ovarian cancer. | Curr Pharm Des | 2014 | Jiang Y | - |
| 24778040 | High levels of Wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer. | Anticancer Res | 2014 May | Liu Z | - |
| 23207289 | The significance of Wilms Tumor Gene (WT1) and p53 expression in curettage specimens of patients with endometrial carcinomas. | Pathol Res Pract | 2013 Jan 15 | Matalka I | doi: 10.1016/j.prp.2012.10.002 |
| 22925896 | WT1 CpG islands methylation in human lung cancer: a pilot study. | Biochem Biophys Res Commun | 2012 Sep 28 | Bruno P | doi: 10.1016/j.bbrc.2012.08.059 |
| 24596380 | Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer. | Anticancer Res | 2014 Mar | Nasomyon T | - |
| 18751389 | The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells. | Anticancer Res | 2008 Jul-Aug | Wang L | - |
| 20204298 | The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells. | Oncol Rep | 2010 Apr | Wang L | - |
| 26406403 | Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer. | Cancer Biomark | 2015 | Miyata Y | doi: 10.3233/CBM-150521. |
| 21710692 | Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. | J Pathol | 2011 Oct | Moelans CB | doi: 10.1002/path.2930 |
| 15674342 | HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. | Oncogene | 2005 Feb 24 | Tuna M | - |
| 15286719 | Transcriptional activation of c-myc proto-oncogene by WT1 protein. | Oncogene | 2004 Sep 9 | Han Y | - |
| 27922671 | Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western blotting and mRNA quantification. | Int J Oncol | 2017 Jan | Maki T | doi: 10.3892/ijo.2016.3786 |
| 29016617 | MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. | PLoS One | 2017 Oct 10 | Xie F | doi: 10.1371/journal.pone.0185565 |
| 29024629 | The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells. | Biochem Biophys Res Commun | 2017 Dec 9 | Bissanum R | doi: 10.1016/j.bbrc.2017.10.043 |
| 29291617 | Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China. | Gut Liver | 2018 Mar 15 | Gao HL | doi: 10.5009/gnl17163. |
| 28345629 | WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel. | Sci Rep | 2017 Mar 27 | Artibani M | doi: 10.1038/srep45255. |
